ArticleInternational wound journal2026
Beta-Glucan: A Macrophage Differentiation Modulator That Accelerates the Wound Healing Response.
Article in International wound journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Beta Glucans (β-glucans) are naturally occurring polysaccharides that have positive effects on healing in acute and chronic wounds. This study aimed to identify how β-glucans modulate macrophage polarisation and inflammation to aid the healing response. Flow cytometry was used to assess the effect of β-glucan on human monocytes during differentiation into M0, M1 and M2 macrophages. Subsequently, a murine full-thickness excisional wound healing model was conducted where wounds were treated with either β-glucan hydrogel or vehicle, at the time of wounding. The wounds were analysed to determine the rate of wound closure, the effect on inflammation, and matrix deposition. β-glucan promoted differentiation of monocytes to M0 macrophages but inhibited differentiation of M0 macrophages to pro-inflammatory M1 macrophages with no effect on M2 macrophage formation. In vivo, treatment of excisional wounds with β-glucan hydrogel accelerated healing with an earlier, more resolved inflammatory phase containing greater numbers of M2 macrophages and fewer neutrophils within the wound. No statistically significant effect on matrix deposition was observed. β-glucans modulate macrophage differentiation and accelerate healing in excisional wounds with no adverse effect on matrix formation. β-glucans are a potential therapeutic approach for treatment of hard-to-heal wounds in humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.